What does treatment feel like and what is the downtime?
Energy-based vaginal treatments (laser or radiofrequency) are usually brief, clinic-based sessions. Most people describe a warm, prickly or pressure sensation; discomfort is typically mild and short-lived. Expect a few days of watery discharge, light spotting or tenderness, and pausing high-friction activities and penetrative sex until comfortable (often 2–7 days). Foundations come first; devices are adjuncts. Educational only. Results vary. Not a cure.
Detailed Medical Explanation
What does treatment feel like and what is the downtime? Energy-based options for mild vaginal laxity or related discomfort generally use fractional CO2/erbium lasers or radiofrequency (RF). The aim is to gently warm the mucosa and submucosa to stimulate collagen turnover and improve surface comfort. A typical session lasts 15–30 minutes. You’ll complete a screening checklist, a pregnancy/infection check, and a brief pelvic exam. A small speculum or handpiece is inserted; settings are chosen to match goals and medical history. Many women describe the sensation as warmth with occasional prickly taps or a feeling of pressure. RF often feels like diffuse heat; fractional lasers feel like brief, spaced pinpricks. Local topical anaesthetic is sometimes used at the vestibule if you’re particularly tender.
Immediately after. The tissue may feel warm and slightly swollen. Watery discharge, light spotting, a “sunburn-ish” tenderness or a metallic/ozone smell can occur for a day or two. Simple measures help: breathable underwear, fragrance-free vulval care, and avoiding vigorous wiping (dab instead). Because micro-channels or transient superficial irritation are possible after some protocols, most clinics advise avoiding swimming pools, hot tubs and high-friction activities for several days, and pausing penetrative sex until you’re comfortable—commonly 2–7 days.
Downtime in practice. You can usually walk out and carry on with light daily tasks. The main adjustments are comfort-based: avoid cycling, long runs, and anything that causes rubbing until tenderness settles. If you’re peri-/post-menopausal with genitourinary syndrome of menopause (GSM), continue your scheduled moisturiser/lubricant and (if acceptable) local vaginal oestrogen; these steps support comfort while tissue settles.
How many sessions and when you notice change. Where devices are chosen, plans often propose 2–3 sessions spaced 4–8 weeks apart. Some people report earlier ease with speculum exams or initial penetration after session one; others notice changes gradually across the series. Because the evidence base is still evolving and durability is variable, we emphasise day-to-day outcomes (less air-trapping, improved tampon retention on active days, calmer sting at the vestibule) rather than promising a specific “tightening” figure.
Foundations first and sequencing. The cornerstones for perceived laxity are a supervised pelvic floor programme (activation, endurance, timing) and GSM care (scheduled moisturiser, a generous compatible lubricant, and—if acceptable—local vaginal oestrogen). Only if specific, entry-focused symptoms persist should devices be considered as adjuncts. To see where a device block sits in our pathway, review how treatment steps are sequenced, and for common practical questions about comfort, spacing and aftercare, check our treatment FAQs.
Expected side-effects and when to seek help. Short-lived warmth, watery discharge, transient spotting and local tenderness are common. Contact the clinic or seek medical advice urgently if you develop fever, worsening pelvic pain, malodorous green/grey discharge, heavy bleeding, visible blood in urine, or new post-menopausal bleeding. Active BV/thrush/UTI should be treated before any energy session.
Why comfort varies person to person. Tissue hydration, GSM status, perineal scar behaviour, pelvic floor over-activity, and the chosen settings all influence comfort. Good placement of local oestrogen (if used)—including a fingertip at the vestibule and posterior fourchette—plus a silicone-based lubricant for the longest glide at a tender entrance can markedly improve the overall experience in the weeks around a session.
Realistic expectations. Energy devices do not correct significant fascial defects, levator avulsion, or a malpositioned perineal scar. They are unsuitable as treatments for deep pelvic pain, endometriosis or prolapse beyond the introitus. If your main limiter is muscle endurance/coordination, pelvic floor rehab remains the most effective lever; devices cannot substitute for training.
Clinical Context
Good candidates. Postnatal or peri-/post-menopausal women with mild, entry-focused symptoms (air-trapping, early-penetration discomfort, reduced “support feel”) that persist after an excellent block of pelvic floor rehab and optimised GSM care. Symptoms should be stable with no active infection or unexplained bleeding.
Who should delay or avoid. Pregnancy, active BV/thrush/UTI, fever, malodorous discharge, new post-menopausal bleeding, immediately after pelvic/perineal surgery without clearance, poorly controlled pelvic pain, suspected prolapse beyond the introitus, or certain implants where electromagnetic interactions are a concern—discuss specifics with your clinician.
Aftercare essentials. Breathable cotton underwear; lukewarm water or bland emollient as a soap substitute; scheduled moisturiser and generous, compatible lubricant for any higher-friction activity (water-based for versatility/condoms; silicone-based for longest glide; avoid oil with latex); resume sex and sport when tenderness settles (often within a week). Track outcomes that matter to you and review at 6–12 weeks.
Evidence-Based Approaches
NICE guidance (menopause context): Recommends first-line use of vaginal moisturisers/lubricants and considering low-dose local vaginal oestrogen when symptoms affect quality of life; device therapies are not routine first-line (NICE NG23).
NICE urinary incontinence/prolapse: Emphasises supervised pelvic floor muscle training as first-line and clear criteria for escalation—principles that underpin selection before considering devices (NICE NG123).
NHS patient information: Practical, plain-English advice on pelvic floor training and when to seek help for related symptoms (NHS pelvic floor exercises).
Cochrane reviews (energy-based therapies): Methods-rigorous overviews of vaginal laser/RF report small studies, varied protocols and short follow-up, supporting cautious, adjunctive positioning and careful consent (Cochrane Library – vaginal laser/radiofrequency).
Regulatory perspective (UK): Information on medical device regulation, marking (UKCA/CE) and vigilance supports safe selection and reporting of suspected adverse events (MHRA – medical devices).
Pathophysiology & GSM (peer-reviewed): Public abstracts summarise how oestrogen decline affects mucosa, pH and microbiota, explaining why GSM care remains central alongside any procedural step (PubMed overview).
